Byluta 50 Tablet

Byluta 50 Tablet belongs to the class of anticancer drugs called non-steroidal anti-androgens used to treat prostate cancer. Prostate cancer is prostate gland cancer (a small gland under the bladder that produces semen) found only in men. The symptoms include difficulty in urination, pain, numbness, or sexual problems.

Byluta 50 Tablet contains Bicalutamide which works by inhibiting the effects of androgens (male hormones) such as testosterone that increase the growth of prostate cancer cells. Byluta 50 Tablet prevents testosterone from binding to androgen receptors on the prostate cancer cells and starves cancer cells of testosterone. Thereby, it prevents the growth of prostate cancer cells and eventually shrinks the prostate tumor.

Take Byluta 50 Tablet with or without food as advised by your doctor and swallow whole with a glass of water. Do not crush, chew or break it. Your doctor will advise you on how often you take your tablets based on your medical condition. In some cases, you may experience weakness, skin rash, swelling and tenderness of the breast, nausea, dry skin, weight gain, hair loss, hot flushes (sudden feeling of warmth), anemia (lack of blood), reduces sex drive, constipation, depression, indigestion or dizziness. Most of these side effects of Byluta 50 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Byluta 50 Tablet or any other medicines, please tell your doctor. Byluta 50 Tablet is not recommended for women and children. Please consult a doctor if you are pregnant or breastfeeding before taking Byluta 50 Tablet. Please consult a doctor if you want to father a child before taking Byluta 50 Tablet as it may impair fertility in men. Avoid taking Byluta 50 Tablet with cisapride, astemizole, or terfenadine. Avoid direct exposure to excessive UV light or sunlight and wear protective clothing while going out in the sun as Byluta 50 Tablet may increase sunburn risk. If you have diabetes, liver, or heart problems, inform your doctor before taking Byluta 50 Tablet.

Byluta 50 Tablet contains Bicalutamide, an anticancer drug used in the treatment of prostate cancer. Byluta 50 Tablet works by inhibiting the effects of androgens (male hormones) such as testosterone that increase the growth of prostate cancer cells. Byluta 50 Tablet prevents testosterone from binding to androgen receptors on the prostate cancer cells and starves cancer cells of testosterone. Thereby, it prevents the growth of prostate cancer cells and eventually shrinks the prostate tumor. Also, Byluta 50 Tablet relieves difficulty in urination. Byluta 50 Tablet can be used in combination with radiation therapy to treat prostate cancer where cancer has spread from the prostate gland to the surrounding tissues.

If you are allergic to Byluta 50 Tablet or any other medicines, please tell your doctor. Byluta 50 Tablet is not recommended for women and children. Please consult a doctor if you are pregnant or breastfeeding before taking Byluta 50 Tablet. You and your partner recommend using effective birth control measures while taking Byluta 50 Tablet and for 130 days after discontinuing Byluta 50 Tablet. Please consult a doctor if you want to father a child before taking Byluta 50 Tablet as it may impair fertility in men. You are advised to quit smoking as it may increase the risk of prostate cancer. Avoid taking Byluta 50 Tablet with cisapride, astemizole, or terfenadine. Regular tests are recommended to monitor liver function and if there is any severe disturbance in liver functioning, avoid taking Byluta 50 Tablet. Avoid direct exposure to excessive UV light or sunlight and wear protective clothing while going out in the sun as Byluta 50 Tablet may increase sunburn risk. If you have diabetes, liver, or heart problems, inform your doctor before taking Byluta 50 Tablet.

Regular blood tests are recommended to monitor changes in blood and liver functioning while taking Byluta 50 Tablet.